The Food and Drug Administration allows for licensed ... the main ingredients in two different FDA-approved diabetes and weight loss drugs. “I did my research, and found what I believed to ...

The company's goal is to use sweet proteins to help consumers reduce the amount of carbohydrate sugar in their diets.

Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...

Innovation Medicine has submitted a request to the US Food and Drug Administration (FDA) to approve a new way of starting ...

The drug has shown strong results in phase 3 clinical trials, which are the basis for the new application to the FDA.

The first ever ‘digital’ pill with a built-in sensor to track compliance has been approved by the FDA, 19 months after being rejected by the agency over safety concerns. Abilify MyCite ...

Executives at Applied Therapeutics told analysts they were surprised by the agency’s refusal to approve the company’s ...

Those treated with tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist, lost on ...

The UbiqVue 2A multi-parameter system biosensor is worn on the chest and collects biodata across 13 monitored parameters.

But no patient who experienced adverse reactions to mifepristone is part of the group that secured an injunction last week in Texas to block FDA approval of a popular drug used to terminate ...

Applied Therapeutics faces challenges after FDA rejection, but future opportunities exist. Learn why APLT stock could recover ...